CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus

Afr Health Sci. 2022 Mar;22(1):361-366. doi: 10.4314/ahs.v22i1.44.

Abstract

Background: The cystine-cystine chemokine receptor 5 (CCR5) is the primary HIV co-receptor involved in the viral entry process into human cells. The 32 bp deletion variant within the CCR5 gene (CCR5-Δ32) plays a very important role in viral recognition and progression of AIDS.

Objective: The current study was aimed at evaluating the CCR5-Δ32 gene variation frequency in Nigerian and Zimbabwean populations residing in Northern Cyprus.

Methods: A total number of 211 subjects (103 Nigerians and 108 Zimbabweans) were analyzed. Nigerian population was further analyzed with respect to the three major ethnicities: Igbo, Hausa, and Yoruba. Polymerase Chain Reaction was used to determine the CCR5-Δ32 gene variant status.

Results: All studied subjects from both sampling groups were homozygous for the CCR5 wild type gene (CCR5-wt), meaning neither heterozygous nor homozygous genotypes of CCR5-Δ32 gene variant were observed.

Conclusion: This study observed the absence of CCR5-Δ32 deletion gene in the Nigeria and Zimbabwean populations living in Northern Cyprus. These populations lack the genetic advantage over HIV infection and may also show a rapid progression towards AIDS. Additionally, these populations could impact the local gene frequency as these two populations interact more and more.

Keywords: CCR5; CCR5-Δ32; HIV; Nigerian; North Cyprus; Zimbabwean.

MeSH terms

  • Acquired Immunodeficiency Syndrome
  • Cyprus
  • Cystine
  • Gene Frequency
  • Genetics, Population
  • Genotype
  • HIV Infections
  • Humans
  • Nigeria
  • Receptors, CCR5* / genetics
  • Zimbabwe

Substances

  • CCR5 protein, human
  • Receptors, CCR5
  • Cystine